Impact of Letermovir Primary Cytomegalovirus Prophylaxis on 1-Year Mortality After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort Study

Viral Infections in HSCT: Detection, Monitoring, Clinical Management, and Immunologic Implications

(2021) Claudio Annaloro et al.   Frontiers in Immunology

Refractory and Resistant Cytomegalovirus after Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era

(2021) Joseph Sassine et al.   CLINICAL INFECTIOUS DISEASES

CMV viral load kinetics predict CMV end-organ disease and mortality after hematopoietic cell transplant (HCT)

(2021) Anat Stern et al.   JOURNAL OF INFECTIOUS DISEASES

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003–2007 Versus 2013–2017 Cohorts

(2020) George B. McDonald et al.   ANNALS OF INTERNAL MEDICINE

Impact of Preemptive Therapy for Cytomegalovirus on Toxicities after Allogeneic Hematopoietic Cell Transplantation in Clinical Practice: A Retrospective Single-Center Cohort Study

(2020) Phaedon Zavras et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

CMV viral load kinetics as surrogate endpoints after allogeneic transplantation

(2020) Elizabeth R. Duke et al.   JOURNAL OF CLINICAL INVESTIGATION

Cytomegalovirus Reactivation Promotes CD8+ T Cell Subset Recovery after Unmodified Allogeneic Hematopoietic Cell Transplantation

(2019) Tania Jain et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT

(2019) Martin Schmidt-Hieber et al.   ANNALS OF HEMATOLOGY

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-Seropositive Recipients of Allogeneic Hematopoietic-Cell Transplantation

(2019) Per Ljungman et al.   CLINICAL INFECTIOUS DISEASES

Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease

(2019) Juan Montoro et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation

(2018) Nicolle H. R. Litjens et al.   Frontiers in Immunology

Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant

(2017) Jenna D. Goldberg et al.   LEUKEMIA & LYMPHOMA

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

(2017) Francisco M. Marty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis

(2016) P. Teira et al.   BLOOD

Cytomegalovirus replication reduces the relapse incidence in patients with acute myeloid leukemia

(2016) A. H. Elmaagacli et al.   BLOOD

Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study

(2016) Margaret L Green et al.   Lancet Haematology

Letermovir

(2014) P.S. Verghese et al.   DRUGS OF THE FUTURE

Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: A 12-year single institution study

(2014) Susan K. Seo et al.   JOURNAL OF INFECTION

Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant

(2014) Izaskun Ceberio et al.   LEUKEMIA & LYMPHOMA

CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT

(2013) M. Schmidt-Hieber et al.   BLOOD

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

(2008) Leo Luznik et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION